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Most come from single cell experiments that quantify molecular events the system uses to operate.
After induction, signal propagation is relatively slow; peak activity takes minutes to reach the
nucleus. At each measurement point along the transmission chain, signal rises, overshoots, peaks,
and declines toward steady state. At at least one measurement point, this decline depends on neg-
ative feedback. The system senses and relays percent receptor occupancy, and one effect of the feed-
back is to maximize precision of this transmitted information. Over time, the system constantly
adjusts quantitative behaviors to convey extracellular ligand concentration faithfully. These behav-
iors and mechanisms that control them are likely to be general for metazoan signaling systems.
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One central distinction between biological systems and com-
plex dynamic non-living systems (from asteroid belts to hurri-
canes) is the centrality of information to the living state. Cells
operate upon information about extracellular conditions, about
internal processes, and upon information stored in their genome,
to make decisions that determine their future actions. The contin-
uing triumphal progress of the molecular biological agenda (begun
in the 1930s [1]) had by the 1990s revealed much of the machinery
that carries out these functions. One important next step is to
understand more formally the relationship between these molecu-
lar components and the ﬂows of information on which they oper-
ate. In order to ﬁnd a relatively accessible entry point to this
complex general issue, my coworkers and I have studied the quan-
titative function of a particular cell signaling system (here, a sys-
tem that senses an extracellular condition, and transmits that
information deeper into the cell).
Like all cell signaling systems, the yeast pheromone response
system operates via chains of molecular events. The system oper-
ates in Saccharomyces cerevisiae, a model eukaryote. S. cerevisiae
is a particularly tractable experimental organism; in particular, it
features facile directed genetic manipulation, it is well suited for
forward genetic experimentation, and it is supported by well-
developed genomic and proteomic resources. Both speciﬁc molec-
ular components of this system (e.g. seven helix G protein coupledchemical Societies. Published by E
gy transfer; RFP, red ﬂuores-
P kinase, mitogen-activated
, dose-response relationship.receptors) and general themes (scaffold proteins, protein kinase
cascades) are widely conserved throughout higher eukaryotic sig-
naling systems.
Fig. 1 depicts some of the molecular details of the system and its
operation. Pheromone binding to the Ste2 receptor causes dissoci-
ation of the single yeast heterotrimeric G-protein into a mono-
meric GTPase, Gpa1, and a dimer, Ste4–Ste18. Upon dissociation
of the G-protein, Ste4 recruits the mitogen-activated protein ki-
nase scaffold, Ste5 to the membrane. (Reassociation of Gpa1 with
Ste4–Ste18 is promoted by the GTP-activating protein (GAP) func-
tion of the regulator of G-protein signaling (RGS-protein) Sst2 (not
shown).) Ste5 recruitment leads to activation of the MAP kinase
cascade, in which each of the protein kinases Ste20, Ste11, Ste7,
and the MAP kinase Fus3 sequentially phosphorylates the next.
Phosphorylated Fus3 translocates to the nucleus and phosphory-
lates Dig1 and Ste12, eliminating Dig1 repression of Ste12, a tran-
scriptional activator. Ste12 activates transcription of pheromone
responsive genes (shown in ﬁgure as PRGs, here gene derivative
that fuses a pheromone-inducible promoter to YFP). Ribosomes
translate mRNAs into proteins. In general, this signaling system
is well understood, and its operation is well reviewed [2].2. Single cell and other methods
When possible, cells are derived from a single reference strain,
ACL 379 [3], which is in turn a descendent of the lab strain W303a.
In particular, the strain carries a loss of function mutation in the
bar1 gene, so that it does not produce the secreted protease that
degrades extracellular pheromone. In addition, most derivatives
carry an inhibitor-sensitive allelic variant of the Cdc28 cell cyclelsevier B.V. All rights reserved.
Fig. 1. Operation of the yeast pheromone response system. Proteins are indicated by labeled ovals, translocation by dotted lines, protein activation by arrows, inhibition by T-
bar arrows, and protein association by double-headed dashed arrows, and measurement points by capital letters. Pheromone binding to the Ste2 receptor causes dissociation
of the single yeast heterotrimeric G-protein into a monomeric GTPase, Gpa1, and a dimer, Ste4–Ste18 (measurement point A in ﬁgure). Reassociation of Gpa1 with Ste4–Ste18
is promoted by the GTP-activating protein (GAP) function of the regulator of G-protein signaling (RGS-protein) Sst2 (not shown). Upon dissociation of the G-protein, Ste4
recruits the MAP kinase scaffold, Ste5 to the membrane (point B in ﬁgure). Ste5 recruitment leads to activation of a protein kinase cascade, in which the proteins Ste20, Ste11,
Ste7, and the MAP kinase Fus3 (and Kss1, not shown) sequentially phosphorylate one another. Phosphorylated Fus3 (point C in ﬁgure) translocates to the nucleus and
phosphorylates Dig1 and Ste12, causing dissociation or conformational change in relationship between Dig1 and Ste12 (point D in ﬁgure), derepressing activation by Ste12, a
transcriptional activator. Ste12 activates transcription of pheromone responsive genes (here, PRG); here, ﬁgure shows a gene derivative which fuses a pheromone-inducible
promoter from the PRM1 gene to YFP. Transcribed mRNA is translated into protein by ribosomes (not shown) into yellow ﬂuorescent protein (YFP, measurement point E).
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sion, and eliminate cell cycle dependent variation from any
measurements.
Descendent strains also carry reporter constructs to enable
quantiﬁcation of different molecular events within the signaling
pathway. By doctrine, when possible reporter constructions re-
place the native chromosomal gene copies with derivatives (such
as ﬂuorescent protein derivatives) expressed from the native pro-
moters. By doctrine, we typically verify that the expression of ﬂuo-
rescent protein derivatives is equivalent to that of the native
proteins by Western gels, comparing the amounts of expressed
proteins to those of wild-type proteins determined from careful
Western gel and ﬂuorescent protein quantiﬁcation [4]. Construc-
tion of most of the strains is described in the main text and supple-
mental materials of three papers, Colman-Lerner et al. [5], Gordon
et al. [4], and Yu et al. [6].
These strains enabled single cell measurements of different
molecular events the system uses to operate. We refer to molecular
events for which we can measure system activity as ‘‘measurement
points” (Fig. 1). These include the recruitment of yellow ﬂuorescent
protein- (YFP-) tagged Ste5 scaffold to the membrane [6] (Colman-
Lerner et al., unpublished) (point B in ﬁgure), de-repression of YFP-
tagged Ste12 and a cyan ﬂuorescent protein- (CFP-) tagged deriva-
tive of the transcription suppressor Dig1 (measured by loss of ﬂuo-
rescence resonance energy transfer (FRET) between these
chromophores) [6]) (D in ﬁgure), and expression of pheromone-
inducible YFP and (red ﬂuorescent protein) RFP reporter genes
[4–6] (E in ﬁgure). We also used unrelated strains, W303 deriva-
tives [7], that carried CFP and YFP G protein reporter constructs en-abling single cell measurements of G protein dissociation (A in
ﬁgure) by loss of FRET.
We induce system activity by single-step additions of phero-
mone to minimal medium [5,6]. We perform cell cytometry and
quantiﬁcation with epiﬂuorescence microscopy, the open source
software package Cell-ID [4], and analyze by canned routines writ-
ten in PAW and R [4,8]. In cell populations, we measure the amount
of phosphorylated and total Fus3 protein kinase by careful quanti-
ﬁcation usingWestern gels probed with antibodies that register to-
tal protein and antibodies that detect activated protein [6], and
second antibodies conjugated to an infrared ﬂuorophore. We mea-
sure the amount of pheromone-induced FUS1 mRNA using a spe-
ciﬁc DNA probe and nuclease protection [6].
3. Signal propagation
Fig. 2a shows the most typical system input regime. At the start
of an experiment, we expose genetically identical cells to a given
external concentration of mating pheromone. The extracellular
medium contains casein to block adsorption of the pheromone to
the inside of the plastic vessel, so that extracellular pheromone
concentration and total system input remain constant thereafter.
Fig. 2b shows propagation of the signal in the ﬁrst few minutes
after system induction [6]. It graphs, on the Y-axis, the total per-
centage activity at four different measurement points, against time
on the X-axis. The utility of this graphic representation is that it
immediately suggests operational ways to deﬁne and quantify sig-
nal propagation and the signal. For example, we can deﬁne peak
signal as 100% of the maximum activity at a given measurement
Fig. 2a. The typical system input regime. At the start of an experiment, we expose
genetically identical cells to a given external concentration of mating pheromone.
The extracellular medium contains casein to block adsorption of the pheromone to
the inside of the plastic vessel, so that extracellular pheromone concentration and
total system input remains constant during the course of the experiment, which can
span hours.
Fig. 2b. Propagation of signal, quantiﬁed from membrane, cytoplasmic, and nuclear
events. Figure (redrawn from Yu et al. (2008)) graphs, on the Y-axis, the total
percentage activity at four different measurement points, against time on the X-
axis. Curve 1 (solid purple line) shows recruitment of Ste5 scaffold to membrane.
Curve 2 (dotted green line) shows phosphorylation of the MAP kinase Fus3. Curve 3
(dashed red line) shows de-suppression of Ste12 (by loss of FRET between tagged
Ste12 and Dig1). Curve 4 (solid black line) shows 50 end of the pheromone-inducible
Fus1 mRNA transcript.
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nucleus as time between peak recruitment of scaffold protein (line
1 in ﬁgure) to membrane and time to dissociation of Ste12 and
Dig1 and depression of the Ste12 transcription activator (line 3).
From such experiments, it becomes sensible to state that propaga-
tion of peak signal to the nucleus takes minutes.
4. Signal dynamics
A second conclusion from plots like those in Fig. 2b is that there
is a common temporal pattern of activation of whatever molecular
events one quantiﬁes at each measurement point. At each mea-surement point, activity rises, peaks, and then declines to (or in
some cases toward) a steady state. Armed with this information,
it becomes sensible to use the terminology that this common dy-
namic behavior reﬂects common signal dynamics.
5. The signal carries information about invariant extracellular
ligand concentration
Insights into system function also come from observation of
quantitative behavior in steady state. One set of observations
comes from quantiﬁcation of cumulative expression of phero-
mone-responsive reporter gene, by measuring accumulation of a
yellow or red ﬂuorescent pheromone-inducible reporter protein
([5] and Pesce et al., unpublished). At a given extracellular phero-
mone concentration, reporter accumulates over time, and the rate
of the accumulation is constant. This observation means that sys-
tem output is constant over time. At increased concentrations of
extracellular pheromone, the rate of reporter protein accumulation
is faster, but remains constant over time. Another way of stating
these observations is that the system senses information about
external pheromone concentration and transmits that information,
through its relay of molecular steps, all the way to the reporter
gene downstream.6. The signal carries updated information about changes in
extracellular ligand concentration
The information the signaling system carries about external
pheromone concentration is updated continually. As measured
by expression of a pheromone responsive reporter gene, when
the extracellular concentration of pheromone is increased after
prolonged operation at lower pheromone input, system output in-
creases to a higher, steady state rate (Pesce et al., unpublished).
This adjustment is rapid. This is apparent from measurement of
system activity at an intermediate measurement point, the amount
of phosphorylated Fus3 MAP kinase. Within minutes after an in-
crease in extracellular pheromone input, the percent of Fus3 that
is phosphorylated (or active) also increases (Yu et al., unpublished).
This behavior after increased extracellular pheromone concentra-
tion is also mirrored in the rapid increase to new steady state of
membrane-recruited scaffold protein at the Ste5 measurement
point (Colman-Lerner, Gordon, et al., unpublished).
7. Dose-response alignment (DoRA)
Fig. 3 shows a remarkable property of the system, which is that,
at different measurement points, dose (or external ligand concen-
tration), and response (as measured system output) are aligned.
That is, the amount of system activity at a given measurement
point (ﬁgure shows two measurement points, G protein dissocia-
tion and reporter gene output) matches closely the calculated per-
centage of the receptor (Ste2) bound by ligand. We term this
relationship between system input and system output ‘‘dose-re-
sponse alignment”, or DoRA.
The existence of DoRA in this signaling system is a simple result,
but one that leads to some strong conclusions. Again, the output of
the system at different measurement points mirrors the percent-
age of occupied surface receptor. Restated, this fact indicates at
least one kind of information the signal carries is the external li-
gand concentration. Moreover, this fact suggests that the system
measures external pheromone concentration by the percentage
of ligand bound surface receptor.
It thus becomes reasonable to view the set of receptors on the
surface of the cell as a sensor for a condition in the extracellular
universe (ligand concentration) and to view this sensor as a device
Fig. 4. Negative feedback in an electrical circuit. Figure redrawn from ‘‘Stabilized
feedback ampliﬁers”, by Black [22]. Black’s cartoon omits all internal workings of
the ampliﬁer system by depicting it as a triangle with deﬁned inputs and outputs.
This representation emphasizes the fact that negative feedback can assure a linear
input/output relationship even given variable and nonlinear relationships among
[whatever] components relay and amplify the signal inside the triangle.
Fig. 3. Dose-response alignment in the yeast pheromone response system.
Figure (redrawn from Andrews et al., submitted) shows the response curve (system
activity) at the upstream G protein dissociation measurement point (dotted orange
line) and the downstream Prm1-YFP pheromone-inducible-reporter gene output
measurement point (dashed blue line; whose activity depends on a minimum of 12
intervening chemical reactions) matches closely the calculated percentage of the
receptor (solid red line) occupied by extracellular pheromone.
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In this view, the molecular events downstream of the sensor relay
this information about the extracellular universe deeper into the
cell, and the cell then operates on this information to make
decisions.
One can consider alignment (DoRA) to be a particular form of a
dose-response relationship (DoRR). It is important to note that this
particular relationship, DoRA, is not new. Numerous vertebrate cell
signaling systems, including the insulin, acetylcholine, thyroid
stimulating hormone, angiotensin II, and epidermal growth factor
response systems, exhibit alignment [9–13]. Frequent alignment
between posited receptor occupancy and cell response was essen-
tial to the work of Clark [14] who built on the by-then-accepted
idea that cell responses to drugs depended on the binding of drug
to particular ‘‘receptive substances” [15]. In fact, for Clark (and
physiologists of his generation) the receptor, whose identity and
nature was of course otherwise unknown, was deﬁned as the mol-
ecule to which the drug bound to exert its biological effects. Given
this assumption, the idea that the percent of maximum cellular re-
sponse might equal the percent bound receptor was simply what
one expected. This idea was so strongly entrenched that, during
the initial era of molecular cloning of receptors (1980s to middle
1990s), binding of drug molecules to particular cloned proteins
at concentrations so that half maximal binding equaled half max-
imal cellular response was frequently adduced as evidence that
the protein of interest was in fact the receptor [16–18].
In fact, it is only after the elucidation of different cell signaling
pathways and the realization that they usually involve relays of
molecular events that the widespread existence of dose-response
alignment becomes a puzzle. My coworkers and I came to realize
the difﬁculty of preserving dose-response alignment through
chains of biochemical reactions without much knowledge of the
relevant scientiﬁc history. However, the relationships between
percent activity in different steps of multi-reaction systems had
been well treated in the early 1980s by Black and Leff [19]. These
researchers showed that without extremely careful attention to
parameters, it is difﬁcult, even in models, to come up with chainsof reactions that preserve dose-response alignment and give high
dynamic range for output. Rather, in any relay of biochemical reac-
tions, a more normal behavior is for the activity curve at each suc-
cessive downstream step to steepen, and to shift to the left.
Restated, the more normal behavior for any chain of reactions is
for the response to external stimulus to become more ‘‘switchlike”
at each downstream step, and to become triggered at lower
amounts of external stimulus.
This property of multistep chemical reaction systems was to
some extent re-discovered during the 1990s – see, for example,
Huang and Ferrell [20] – who showed, by model and experiment
in Xenopus laevis ooctyes, that the response of downstream steps
of protein kinase cascades become progressively more sensitive
(and, again, as the response curve steepened, more ‘‘switchlike”).
Consideration of other previous work also suggested one means
by which multi-component systems can adjust their behavior to
attain linear input/output relationships, even given nonlinear
interactions among internal components. That is of course the
use of negative feedback, as ﬁrst analyzed by Maxwell [21] and
worked out in electrical circuits by Harold Black at Bell Labs
(1934, Fig. 4) [22]. In fact, we have shown that in the pheromone
response system, good dose-response alignment at the MAPK mea-
surement point requires protein kinase activity of Fus3, acting up-
stream to suppress a previously-unidentiﬁed positive function of
the RGS protein Sst2 [6].
However, even given this identiﬁed instance of negative feed-
back, the preservation of dose-response alignment over many
hours of system induction is nothing short of remarkable. During
system operation, there are wholesale changes in cell morphology
and in levels of system proteins [2]. It seems likely that additional
control mechanisms must operate during this time to maintain
alignment (see Section 8).
One consequence of dose-response alignment is to increase the
precision of the transmitted signal and the cellular response [6].
Much of the reasoning and experimentation that establish this
point is now largely unpublished, and a detailed account of all
the different ways that downstream alignment increases signal
information content is thus beyond the scope of this review.
Fig. 5. Misalignment of upstream and downstream response can decrease the
ﬁdelity of transmitted information about extracellular ligand concentration.
Figure shows one means by which this occurs. Figure shows activity at a
downstream measurement point for a system in which the dose response is shifted
to become more sensitive. Solid black line shows upstream response, dashed line,
downstream response. Gray box shows a range of input ligand concentrations in
which small differences in upstream response (bottom brackets, due for example to
stochastic noise in signal transmission farther upstream) are ampliﬁed into larger
differences in downstream response (top brackets).
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ity at a downstream measurement point for a system in which the
dose response is shifted to become more sensitive. One conse-
quence of this shift is to make the downstream response more sen-
sitive to, for example, stochastic noise due to random molecular
collisions during signal transmission.
8. Discussion and avenues for future work
So far, perhaps the most important accomplishment from the
previous years of painstaking work on the system has simply been
to identify questions that should reward future study. Although
there has yet been comparatively little work detailing the quanti-
tative behaviors of cell signaling systems per se, there are a great
many pertinent observations from 20th century pharmacology that
one must now interpret through the knowledge of the signaling
systems responsible for the measured pharmacological effects. Ta-
ken together, both lines of research establish the point that certain
quantitative signaling system behaviors, including dynamic behav-
iors such as signal overshoot and decline toward equilibrium by
negative feedback, and certain steady state behaviors, such as
dose-response alignment and its consequent increase in the infor-
mation carrying capacity of the signaling channel, are very widely
conserved.
There are numerous important questions about mechanisms
and system behaviors. For mechanisms, among the most important
questions concern the molecular means by which different levels
of different cell signaling systems encode information about extra-
cellular conditions. In 1997, Kholodenko and coworkers published
a theoretical treatment that posited that each level of a signaling
relay consisted of an active and inactive form of a protein, and that
signal was carried by the amount of active protein [23]. For lack of
a better term, one can call coding schemes like that implicit in this
work ‘‘amplitude modulation”. Our ﬁnding of dose-response align-
ment at many levels of system operation [6] is consistent with
amplitude encoding schemes. That is, our ﬁndings are consistent
with the idea that at each step in the chain information about
external ligand concentration is encoded in percent active form
of some particular system intermediate. But, taken literally, theprevious statement would suggest that the system might know
the possible percent maximum activity (which seems unlikely) or
alternatively that it counts, at different steps, ratios of active and
inactive states (which seems possible). Moreover, nothing in our
results is inconsistent with the possibility that the dose informa-
tion (a kind of ‘‘control information”, see below) might be encoded
by different molecules than those the system uses for its operation.
It thus remains possible that at some levels in the yeast system and
other signaling systems, dose information might be transmitted by
as-yet-unknown molecular events.
In the yeast pheromone response system, one postulated ampli-
tude encoding scheme is worth mentioning. Dohlman, Elston, and
coworkers [24,25] quantiﬁed MAP kinase activity during phero-
mone signaling. They did so using different yeast strains, different
immunological methods, and longer time intervals than my
coworkers and me. Dohlman, Elston and coworkers ﬁnd that at
low system inputs the total amount of activated MAP kinase peaks,
then declines. These observations led the authors to suggest that
the total system activation is a function of the extent and time over
which the MAP kinases remain active, an idea they term ‘‘dose-to-
duration” encoding. We have not yet sought to reconcile their ﬁnd-
ings of transient MAP kinase activation with our ﬁndings of steady
state activation at many steps at earlier times, and for very long
times at more downstream steps. Whatever the explanation, their
results are consistent with their proposed amplitude encoding
scheme. Moreover, their results are also consistent with schemes
in which dose information at some steps of system operation is
carried by now-unidentiﬁed molecular events.
Finally, there is evidence consistent with a different encoding
scheme for certain intracellular signaling events. This comes from
elegant work by Elowitz and coworkers [26 and this volume]. In
individual yeast cells, the cellular complement of the Calcium
stimulated transcription activator Crz1 localizes stochastically
and transiently to the nucleus. The frequency of these localization
bursts depends on (extracellular and intracellular) calcium concen-
tration. These results are nicely accounted for if the level of expres-
sion of calcium-responsive genes depends on the frequency of
localization bursts, or on the aggregate residence time of Crz1 in
the nucleus. In this case, at the level of system operation, informa-
tion about [intracellular] calcium concentration may be encoded in
the frequency with which Crz1 localizes to the nucleus.
Of course, there are important questions about other mecha-
nisms than those that represent the dose information. For example,
it seems possible that system output at the far-downstream pher-
omone-inducible-reporter measurement point (E in Fig. 2b) must
stay in alignment with occupied receptor because of additional
feedbacks originating further downstream than the single one we
have now identiﬁed at Fus3 MAP Kinase. If such downstream feed-
backs exist, it will be possible to ﬁnd them and ﬁgure out how they
work. Similarly, if, as now seems to be the case, this and other sig-
naling systems sense and relay extracellular ligand concentration
by measuring percent receptor occupancy, that suggests that cell
signaling systems might have one or more mechanisms that count
total surface receptors or un-occupied receptors. The molecular
means by which such counting mechanisms (if these exist) func-
tion, are now wholly unknown. Going forward, one can expect that
forward genetic studies will identify additional possible quantita-
tive regulatory mechanisms. I am optimistic that existing and new-
ly devised genetic, biochemical, and single cell physiological tools
will be able to establish how these function in the yeast system,
and that these insights will be relevant to conserved function in
higher eukaryotes.
Although it may be more difﬁcult to identify good ‘‘systems
level” questions about cell signaling systems, this task also seems
possible. For example, it now appears likely that the system main-
tains one of its quantitative behaviors, dose-response alignment,
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bers of system proteins, and that a consequence of this adjustment
is to maximize the information carrying capacity of the signaling
channel. This assertion is an example of a possible unifying princi-
ple or ‘‘design property” of cell signaling systems. That is, it is an
example of a simplifying abstraction that provides explanations
for a number of otherwise disparate observations.
Other ‘‘systems-level” observations (and perhaps simplifying
answers) might come from consideration of the origins and archi-
tecture of cell signaling systems. In particular, it is said to be axi-
omatic in control theory that all dynamic systems with a
predictable relationship between input and output separate oper-
ation from control [27]. In fact, it appears possible at this point
(Resnekov, Maxwell et al., unpublished) that some sites of phos-
phorylation on system proteins that change after system induction
are needed for system operation, while other sites are required for
system control, that is, regulation of quantitative behavior. But
one difference between the systems studied by control theory
and cell signaling systems is that the latter systems were not de-
signed by thinking engineers. For example, when compared with
von Neumann computers, biological systems (including cell signal-
ing systems) lack crisp distinction between processing functions
and ‘‘output” [28]. Rather, in biological systems, ‘‘output” is best
deﬁned a ‘‘biological function” or ‘‘phenotype” upon which selec-
tion operates. Selection can operate simultaneously at many levels
within cells and organisms, not all of these are known, and not all
of which may be knowable [28]. If cell signaling systems some-
times transmit control information (such as ligand dose) without
separating operation from control, and we can learn how they do
so, then those ﬁndings might suggest paths for human engineers
to design controlled dynamical systems different from those today.
Finally, additional insight into quantitative behaviors of cell sig-
naling systems should of course provide insight into normal and
disease function from humans and other multicellular organisms.
The reason is that signaling systems sense and relay information
cells use to make decisions pertinent to proper development and
(cancer free) maintenance of the adult soma. It seems likely that
dysfunctions in the proteins that control quantitative function of
cell signaling systems, and the genes that encode them, may lead
to aberrant development and adult disease, and that some of the
proteins that control these mechanisms (such as protein kinases)
might thus become targets for small molecule pharmacological
intervention.
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